Literature DB >> 27558465

Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection.

E Keoshkerian1, M Hunter2, B Cameron2, N Nguyen2, P Sugden2, R Bull1, A Zekry3, L Maher4, N Seddiki5, J Zaunders6, A Kelleher6, A R Lloyd1.   

Abstract

Clearance of primary hepatitis C virus (HCV) infection has been associated with strong and broadly targeted cellular immune responses. This study aimed to characterize HCV-specific CD4+ effector and regulatory T-cell numbers and cytokine production during primary infection. Antigen-specific CD4+ T-cell responses were investigated in a longitudinal cohort of subjects from pre-infection to postoutcome, including subjects who cleared [n=12] or became chronically infected [n=17]. A cross-sectional cohort with previously cleared, or chronic infection [n=15 for each], was also studied. Peripheral blood mononuclear cells were incubated with HCV antigens and surface stained for T-effector (CD4+CD25high CD134+CD39-) and T-regulatory (CD4+CD25high CD134+CD39+) markers, and culture supernatants assayed for cytokine production. Contrary to expectations, the breadth and magnitude of the HCV-specific CD4+ T-cell responses were higher in subjects who became chronically infected. Subjects who cleared the virus had HCV-specific CD4+ T-cell responses dominated by effector T cells and produced higher levels of IFN-γ, in contrast to HCV-specific CD4+ T-cell responses dominated by regulatory T cells and more IL-10 production in those who became chronically infected. Better understanding of the role of antigen-specific CD4+ T-cell responses in primary HCV will further define pathogenesis and help guide development of a preventative vaccine.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  T effectors; T regulatory cells; acute hepatitis C; antigen-specific CD4 T cells; cytokines

Mesh:

Substances:

Year:  2016        PMID: 27558465     DOI: 10.1111/jvh.12576

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  6 in total

1.  CD4+ T cell responses in human viral infection: lessons from hepatitis C.

Authors:  Benedikt Binder; Robert Thimme
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 2.  Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long-Term Relationship.

Authors:  Ratna B Ray; Ranjit Ray
Journal:  Hepatology       Date:  2019-02       Impact factor: 17.425

Review 3.  Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.

Authors:  Julia L Casey; Jordan J Feld; Sonya A MacParland
Journal:  Cells       Date:  2019-04-05       Impact factor: 6.600

4.  Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus Infection.

Authors:  Melanie R Walker; Auda A Eltahla; Michael M Mina; Hui Li; Andrew R Lloyd; Rowena A Bull
Journal:  Viruses       Date:  2020-01-08       Impact factor: 5.048

Review 5.  Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment.

Authors:  Srikanta Dash; Yucel Aydin; Kyle E Widmer; Leela Nayak
Journal:  J Hepatocell Carcinoma       Date:  2020-04-15

Review 6.  Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal.

Authors:  Alip Ghosh; Sara Romani; Shyam Kottilil; Bhawna Poonia
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.